The purpose of this study is to compare the frequency with which pseudolesions around the gallbladder (GB) fossa are revealed by multiphasic CT, by CT during arterial portography (CTAP), and by CT during hepatic arteriography (CTHA) and to determine their radiological characteristics.
probability of detecting hepatic lesion (1 3) . But numerous false-positive lesions may, however, be well established in various regions; they may occur, for example, around the falciform ligament and in the subcapsular region.
Pseudolesions adjacent to the gallbladder fossa are also frequently demonstrated by conventional CT and CTAP (4 8) and one report has described the frequency of pseudolesions adjacent to the gallbladder fossa, as seen on CTHA (9).
The purpose of our study is to compare the frequency with which pseudolesions around the gallbladder fossa are revealed by multiphasic CT, CTAP, and CTHA, and to determine their radiologic characteristics.
The results of all available multiphasic CT, CTAP, and CTHA examinations performed at our institution between February 1996 and February 1998 were retrospectively reviewed. The study group consisted of 81 patients (56 men and 25 women) ranging in age from 30 to 80 (mean 56) years. Sixty patients had liver cirrhosis. All 81 underwent multiphasic CT, CTAP, and CTHA; in each case, the purpose of multiphasic CT was to evaluate the hepatic lesions revealed by ultrasonography, while that of CTAP and CTHA was to differentiate the hepatic lesions. Diagnoses of hepatocellular carcinoma, metastatic liver cancer, peripheral cholangiocarcinoma, and hypereosinophilic syndrome were confirmed pathologically (n=37) or radiologically (n=44). Patients whose gallbladder or adjacent gallbladder fossa harbored a pathologic condition, or in whom CT images revealed severe arterioportal shunt, were excluded.
For multiphasic CT, CTAP, and CTHA scanning, a spiral CT Somatom Plus S scanner 40B (Siemens, Erlangen, Germany) was used. Scanning extended from the basal lung zone to the lower pole of the right kidney. Nonionic contrast medium (Ultravist 300, Schering, Berlin, Germany) or Omnipaque (Iohexol, Nycomed, Oslo, Norway) was used. Table feed was 10 mm/sec, with 10 mm collimation, and scans were obtained at 165 or 210 mA and 120 kVp. Overlapping axial reconstructions were obtained at 10 mm intervals.
In the case of multiphasic CT, 140 ml of contrast medium was administered at a rate of 3 ml/sec by power injector (MEDRAD, Pittsburgh, Pa., U.S.A.). In the case of biphasic CT, scan delay time was 24 27 sec (arterial phase) or 3 min (delayed phase) after starting the injection of contrast medium. In the case of triphasic CT, scans were also obtained 58 62 secs after the injection of contrast medium (portal phase). Patients were instructed to hold their breaths during spiral CT examination.
To ensure correct catheter placement and to evaluate hepatic arterial anatomy, superior mesenteric and celiac arteriography was performed prior to CT scanning. A 4-Fr Yashiro catheter (Jung Sung Corp., Seoul, Korea) was positioned in the common hepatic artery (CTHA) and superior mesenteric artery (CTAP) distal to the takeoff of any replaced or accessory hepatic arterial branches. During each angiographic sequence, patients received less than 20 ml of contrast medium at a rate of 2 5 ml/sec. They were then taken to the CT suite.
For CTAP, 80 ml of contrast medium was injected at a rate of 2 ml/sec through the superior mesenteric artery. Scans were obtained 40 sec after injection of contrast medium.
For CTHA, 20 35 ml of contrast medium was injected at a rate of 1.0 1.2 ml/sec through the common or proper hepatic artery. In the case of a narrow or tortuous artery, coaxial 3-Fr SP microcatheter (Terumo, Tokyo, Japan) was introduced through a 4-Fr catheter and 24 ml of contrast medium was injected at 1.0 ml/sec. Scan delay time was 6 sec after the injection of contrast medium.
The definition of pseudolesion around the gallbladder fossa was as follows: 1) hyperattenuation during the arterial phase and isoattenuation during the delayed phase of multiphasic CT, or perfusion defect on CTAP and hyperattenuation on CTHA; 2) no Lipiodol tagging on Lipiodol CT; 3) all findings observed adjacent to the gallbladder fossa; and 4) no interval change on follow-up CTAP and CTHA.
Three radiologists retrospectively analysed the findings of multiphasic CT, CTAP, and CTHA. The three modalities were reviewed Independently prior to sideby-side evaluation. The observers specifically searched for abnormal findings around the gallbladder fossa which would satisfy the above definition of pseudolesion. The location, size, and shape of abnormal findings, especially of those seen on CTHA, were recorded. For each lesion, the longest diameter, as seen on CT images, was measured, and this same diameter as seen on CTAP and CTHA was also recorded. With regard to shape, lesions were classified as wedge-like, round, oval, or band-like. All decisions were reached under the consensus of all observers.
Using Chi-square test, we determined whether there was a difference in the frequency of each pseudolesion between patients with and without liver cirrhosis. The threshold of statistical significance was <0.05.
Pseudolesions were not pathologically confirmed, except in one case. In this patient, an ultrasonogram-guided gun biopsy was performed using a 19.5 gauge gun.
A comparison of the frequency of pseudolesions, as seen on multiphasic CT, CTAP, and CTHA is shown in Table 2 . Although pseudolesions were seen on multiphasic CT in only two patients, CTAP and CTHA revealed their presence around the gallbladder fossa in 43 of 81 (Fig. 1) . In these 43, CTAP and CTHA demonstrated 58 pseudolesions; among this same group, CTHA failed to show the pseudolesion in one patient and CTAP in a further two. Fifty-six of 58 pseudolesions were identified on CTAP (96.6%) and 57 on CTHA (98.3%), a finding which reveals no statistical difference between CTAP and CTHA (p=0.14) (Fig. 2) .
The size of pseudolesions ranged from 5 to 30 (average, 17.5)mm. Forty-nine of 58 pseudolesions (84.5%) appeared larger on CTHA than on CTAP (p=0.01) (Fig. 3) .
On CTHA, 32 pseudolesions (55.2%) were located in segment V, 25 (43.1%) in segment IV, and one (1.7%) in Pseudolesions were most commonly wedge-shaped (48 of 58, 82.8%); the oval form was next most frequent, followed by badn-like and round (Table 3) . Table 4 . shows the relationship between frequency of pseudolesions and liver cirrhosis. The prevalence of pseudolesions was not significantly different between the group without and with liver cirrhosis (p=0.232). In one pseudolesion, the pathologic finding was hyperplasia of hepatocytes, without evidence of malignan- CTAP is the most sensitive modality for detecting hepatic neoplastic lesion but its specificity is low. Non-tumoral perfusion defects in various regions have been visualized on CTAP, and pseudolesion around the gallbladder fossa is also well known (4 8). CTHA is also highly sensitive but its low specificity results in various false positive findings (9).
The cause of pseudolesion adjacent to the gallbladder fossa, namely increased cystic venous drainage is also well known (10 12). Matsui et al. concluded that increased cystic venous drainage into the intrahepatic portal vein in the gallbladder bed was the cause of the staining seen in the nondiseased gallbladder bed using CTAP and hepatic arteriography (13) . Using CT during cystic arteriography, Yoshimitsu et al. demonstrated hyperattenuation around the gallbladder fossa caused by cystic venous drainage (14) .
Several authors have reported pseudolesion around the gallbladder fossa (4 7). The highest frequency (39%, as seen on CTAP) has been demonstrated by Blumke et al (7) . They noted, in addition, two morphologically distinct types with equal frequency. One type of defect was somewhat lobulated in appearance and extended approximately 15 22 mm along the gallbladder fossa. Other defects were focal and wedge-shaped, with a size of 8 10 mm. Our result showed a higher frequency of pseudolesion around the gallbladder fossa (50.6% for CTAP and 51.8% for CTHA). Examination of the findings of follow-up CTAP and CTHA explains the higher frequency of pseudolesions in out study, permitting their easy visualization. Between week 4 and week 12, pseudolesions adjacent to the gallbaldder fossa showed no definite interval change in size or shape, and this allowed us to differentiate pseudolesion from true tumoral lesion. Follow-up CTAP and CTHA were available in all cases.
The use of Lipiodol CT allowed easy differentiation of pseudolesion from true tumoral lesion; in pseudolesions, Lipiodol uptake was not seen.
In our study, the fact that multiphasic CT revealed a lower frequency of pseudolesions than did CTAP is remarkable. In many cases, a retrospective review of multiphasic CT on the basis of CTAP and CTHA did not reveal the presence of pseudolesion. This was due to several factors, one of which was the influence of liver cirrhosis. Most hepatocellular carcinomas were found in cases of liver cirrrhosis, which in our study was frequent (60/81, 74.1%). In liver cirrhosis, massive, confluent fibrosis can appear hypodense to remaining liver parenchyma on noncontrast CT, and often becomes either isodense or hypodense following contrast administration (15) . This appearance may cause difficulty when locating pseudolesions on multiphasic CT images.
CTAP and CTHA revealed a similar frequency of pseudolesion around the gallbladder fossa, but on CTHA, most pseudolesions appeared to be larger, and showed better contrast to hepatic parenchyma, than on CTAP. The reason of this result is unclear. Pseudolesions present as perfusion defect or negative lesion on CTAP were seen as areas of hyperperfusion or positive lesion and on CTHA; these last-mentioned features were more easily identified after the infusion of contrast media. Arterioportal communication via the peribiliary arterial plexus has also been noted (16) . Infused contrast media might diffuse to surrounding normal hepatic parenchyma, resulting in the appearance on CTHA images of pseudolesions apparently larger than their actual size.
Frequent sites of pseudolesions were segment V and IV. According to a previous study by Yoshimitsu et al., the sites of cystic venous drainage were segment V (96%), segment IV (93%), segment I (21%), and segment VI (18%) (14) ; their findings were similar to ours.
Pseudolesions were typically wedge-shaped, but other forms such as round, oval, or band-forms also occurred. Round pseudolesions, in particular, with a reported frequency of ten percents (7), must be differenciated from tumors. In our study, one of 58 pseudolesions (1.7%) was round, and on the basis of follow-up CTAP and CTHA was easily differentiated from tumors.
Irie et al. suggested that liver cirrhosis does not influence the frequency of pseudolesions adjacent to the gallbladder fossa (17) , and our study shows the same results. The cause of pseudolesion around the gallbladder fossa is increased cystic venous drainage into the intrahepatic portal vein and even in the case of portal hypertension, frequently seen in liver cirrhosis, cystic venous blood is not distributed to the portal vein of the gallbladder bed. For this reason, there is no relation between liver cirrhosis and pseudolesions adjacent to the gallbladder fossa.
A limitation of our study is that only one case was pathologically confirmed, and correlation between the radiological and pathological results was thus not demonstrated. In one case, the result was hyperplasia of hepatocytes. Soyer et al. demonstrated that various entities of pathologic diagnosis, including focal fatty infiltration and cirrhotic or normal liver, appeared on CTAP images as non-tumoral perfusion defect (18) , while other studies have concluded that focal fatty infiltration is the cause of pseudolesion of the liver, especially in the left lobe (4 6, 19) . Because focal fatty infiltration is seen on CTHA as an area of low attenuation, a diagnosis of focal fatty infiltration may be excluded from our study.
In conclusion, hepatic pseudolesions around the gallbladder fossa are frequently seen on CTAP and CTHA images. Pseudolesions were between 5 and 30 mm in size, most frequently wedge-shaped, and most commonly located in segments V and IV. On the basis of these characteristics, pseudolesions and true tumoral lesions may be more easily differentiated.
